Company Filing History:
Years Active: 1998-2005
Title: McKeough Carlin: Innovator in Biotechnology
Introduction
McKeough Carlin is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies and related proteins. With a total of 5 patents to his name, Carlin's work has had a substantial impact on medical research and treatment methodologies.
Latest Patents
Carlin's latest patents include groundbreaking discoveries related to human IL-17F and other CTLA-8-related proteins. His patents disclose polynucleotides encoding human CTLA-8, now known as IL-17F, and related proteins. Additionally, he has developed methods for producing anti-human IL-17F antibodies and outlined treatment methods using human CTLA-8 proteins, rat CTLA-8 proteins, and herpes CTLA-8 proteins. These innovations are crucial for advancing therapeutic approaches in immunology.
Career Highlights
Throughout his career, McKeough Carlin has been associated with Genetics Institute, Inc., where he has played a vital role in research and development. His expertise in biotechnology has led to significant advancements in the understanding and treatment of various diseases.
Collaborations
Carlin has collaborated with notable colleagues, including Kenneth A Jacobs and Kerry Kelleher. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
McKeough Carlin's contributions to biotechnology through his patents and collaborations highlight his role as a key innovator in the field. His work continues to influence medical research and treatment strategies, showcasing the importance of innovation in healthcare.